Daniel Solomon urges reform of Medicare reimbursement policy while a new U.S. Customs and Border Protection rule threatens affordable drug imports from Canada.
1 report, 1 independent
Updated Mon 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Daniel Solomon urges reform of Medicare reimbursement policy while a new U.S. Customs and Border Protection rule threatens affordable drug imports from Canada.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Medicare
US federal health insurance
-
U.S. Customs and Border Protection
customs service of the United States since 2003
Related events
- The Trump administration is implementing new border rules and regulatory changes regarding prescription drug shipments from Canada.
- Tariffs are introducing uncertainty into the drug market structure.
- Slotkin argues Medicare should negotiate drug prices while criticizing Trump's proposed tariffs on generic drugs.
- In Colorado, the program utilizing the ACA marketplace is setting reimbursement floors relative to Medicare, announced by Governor Polis's office.
- Donald Trump announced a discounted drug program for Medicare recipients, which is currently undergoing financial feasibility review by the Congressional Budget Office.